Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?

被引：0
|
作者：
Symon, Z. [1 ]
Saad, A. [1 ]
Even-Sapir, E. [2 ]
Ben-Haim, S. [1 ]
Davidson, T. [1 ]
Weiss, I. [1 ]
Berger, R. [1 ]
Sarit, A. [1 ,2 ]
Goldstein, J. [1 ]
机构：
[1] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2597
引用
收藏
页码：S448 / S448
页数：1
相关论文
共 50 条
  • [21] [11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY.
    Suardi, Nazareno
    Briganti, Alberto
    Gallina, Andrea
    Abdollah, Firas
    Di Muzio, Nadia Gisella
    Passoni, Niccolo Maria
    Fossati, Nicola
    Gianolli, Luigi
    Messa, Maria Cristina
    Giovacchini, Giampiero
    Scattoni, Vincenzo
    Guazzoni, Giorgio
    Rigatti, Patrizio
    Montorsi, Francesco
    JOURNAL OF UROLOGY, 2012, 187 (04): : E76 - E76
  • [22] 11C-Choline PET/CT in the Diagnostics of Bone Metastases in Prostate Cancer Patients with Biochemical Relapse
    Pursanova, D. M.
    Aslanidi, I. P.
    Mukhortova, O. V.
    Katunina, T. A.
    Shirokorad, V. I.
    Roschchin, D. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S700 - S701
  • [23] 18F-Choline PET/CT and Prostate MRI for Staging Patients With Biochemical Relapse After Irradiation for Prostate Cancer
    Quero, Laurent
    Vercellino, Laetitia
    de Kerviler, Eric
    Mongiat-Artus, Pierre
    Culine, Stephane
    Merlet, Pascal
    Ravery, Vincent
    Meria, Paul
    Desgrandchamps, Francois
    Hennequin, Christophe
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (11) : e492 - e495
  • [24] Role of 11C-Choline PET/CT in prostate cancer patients with biochemical recurrence after brachytherapy
    Garcia, J.
    Cozar, M.
    Soler, M.
    Reyes, G.
    Diaz, A.
    Ferrer, J.
    Riera, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S699 - S699
  • [25] [11C]CHOLINE PET/CT PREDICTS SURVIVAL IN HORMONE NAIVE PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY
    Picchio, Maria
    Giovacchini, Giampiero
    Gianolli, Luigi
    Suardi, Nazareno
    Abdollah, Firas
    Gallina, Andrea
    Cucchiara, Vito
    Gandaglia, Giorgio
    Bianchi, Marco
    Scattoni, Vincenzo
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF UROLOGY, 2015, 193 (04): : E829 - E829
  • [26] Standardization of acquisition protocol of 18F-choline PET/CT in prostate cancer patients with biochemical relapse
    Chondrogiannis, S.
    Marzola, M. C.
    Grassetto, G.
    Maffione, A. M.
    Secchiero, C.
    Rampin, L.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S393 - S393
  • [27] Prostate-specific antigen kinetics and choline PET/CT in patients with biochemical relapse after primary treatment for prostate cancer
    Castellucci, Paolo
    Fuccio, Chiara
    Marzola, Maria Cristina
    Al-Nahhas, Adil
    Rubello, Domenico
    Fanti, Stefano
    NUCLEAR MEDICINE COMMUNICATIONS, 2011, 32 (06) : 475 - 478
  • [28] Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
    Gomez-de la Fuente, Francisco J.
    Martinez-Rodriguez, Isabel
    De Arcocha-Torres, Maria
    Quirce, Remedios
    Jimenez-Bonilla, Julio
    Martinez-Amador, Nestor
    Sanchez-Salmon, Aida
    Lucas-Velazquez, Blanca
    Cuenca-Vera, Oriana
    Banzo, Ignacio
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (01) : 79 - 85
  • [29] Does Using Choline PET Scans in Patients with Prostate Cancer Alter Management? A South Wales Experience
    Bowden, C.
    Staffurth, J.
    Tanguay, J.
    Rees, J.
    CLINICAL ONCOLOGY, 2019, 31 (02) : E21 - E21
  • [30] Choline PET/CT for imaging prostate cancer: an update
    Kazuhiro Kitajima
    Robert C. Murphy
    Mark A. Nathan
    Annals of Nuclear Medicine, 2013, 27 : 581 - 591
12345